Medinotec (MDNC) holders unanimously elect directors, ratify 2026 auditor

Rhea-AI Filing Summary

Medinotec, Inc. reported the results of its 2025 Annual Meeting of shareholders held on January 20, 2026. Shareholders elected five directors — Gregory Vizirgianakis, Pieter van Niekerk, Stavros G. Vizirgianakis, Joseph P. Dwyer and Athanasios Spirakis — each to a one-year term expiring at the 2026 Annual Meeting or until their successors are elected and qualified. Each director received 9,955,835 votes for, with no votes against or abstentions. Shareholders also ratified the appointment of Mercurius & Associates LLP as the independent registered public accounting firm for fiscal 2026, with 9,955,835 votes for, and no votes against or abstaining.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Understanding 8-K Material Events →

false 0001931055 0001931055 2026-01-20 2026-01-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
____________________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 20, 2026

Medinotec, Inc.
(Exact name of registrant as specified in its charter)

Nevada	000-56737	36-4990343
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

Northlands Deco Park | 10 New Market Street | Stand 299 Avant Garde Avenue North Riding | Johannesburg | South Africa	2169
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: +27 87 330 2301

________________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   [X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      [ ]

SECTION 5 – Corporate Governance and Management

Item 5.07 Submission of Matters to a Vote of Security Holders.

On January 20, 2026, we held our 2025 Annual Meeting of the shareholders, at which the shareholders voted on the matters disclosed in our Proxy Statement. The final voting results for the matters submitted to a vote of the shareholders were as follows:

Proposal No. 1 - Election of Directors

Our shareholders elected the persons listed below for a one-year term expiring at our 2026 Annual Meeting or until their respective successors are duly elected and qualified:

			FOR						AGAINST						ABSTAIN
Gregory Vizirgianakis			9,955,835						0						0
Pieter van Niekerk			9,955,835						0						0
Stavros G. Vizirgianakis			9,955,835						0						0
Joseph P. Dwyer			9,955,835						0						0
Athanasios Spirakis			9,955,835						0						0

Proposal No. 2 – Ratification of Independent Registered Public Accounting Firm

Our shareholders ratified the appointment of Mercurius & Associates LLP  as our independent registered public accounting firm for fiscal 2026.

	FOR		AGAINST		ABSTAIN
	9,955,835		0		0

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Medinotec, Inc.

/s/ Pieter van Niekerk

Pieter van Niekerk
Chief Financial Officer

Date: January 20, 2026

3

FAQ

What did Medinotec, Inc. (MDNC) shareholders vote on at the 2025 Annual Meeting?

Shareholders voted on two items: the election of five directors for one-year terms and the ratification of Mercurius & Associates LLP as the independent registered public accounting firm for fiscal 2026.

Who was elected to the Medinotec, Inc. (MDNC) board of directors?

Shareholders elected Gregory Vizirgianakis, Pieter van Niekerk, Stavros G. Vizirgianakis, Joseph P. Dwyer and Athanasios Spirakis to the board for one-year terms expiring at the 2026 Annual Meeting or until their successors are elected and qualified.

What were the vote totals for Medinotec, Inc. (MDNC) director elections?

Each director nominee received 9,955,835 votes for, with zero votes against and zero abstentions, reflecting unanimous support among shares voted.

Which auditing firm did Medinotec, Inc. (MDNC) shareholders ratify for fiscal 2026?

Shareholders ratified Mercurius & Associates LLP as Medinotec, Inc.’s independent registered public accounting firm for fiscal 2026, with 9,955,835 votes for and no votes against or abstaining.

What SEC item does this Medinotec, Inc. (MDNC) 8-K relate to?

The report relates to Item 5.07, Submission of Matters to a Vote of Security Holders, summarizing the final voting results from the 2025 Annual Meeting of shareholders.

Is Medinotec, Inc. (MDNC) classified as an emerging growth company?

Yes. Medinotec, Inc. indicates that it is an emerging growth company as defined under SEC rules.